Skip to content
Search

Latest Stories

NHS England chief Amanda Pritchard steps down, Sir James Mackey named successor

Sir James Mackey will formally take over as NHS England's chief executive on 1 April.

NHS England chief Amanda Pritchard steps down

Amanda Pritchard

REUTERS

Amanda Pritchard has announced her decision to stand down as chief executive of NHS England at the end of this financial year.

Pritchard, who has led NHS England since August 2021, made history as the first woman to hold the post, playing a pivotal role in steering the NHS through the Covid-19 pandemic. Previously, she served as chief operating officer from 2019.


Before joining NHS England, she served as chief executive of Guy’s and St Thomas’ NHS Foundation Trust, deputy chief executive at Chelsea and Westminster NHS Foundation Trust and a health team leader in the Prime Minister’s Delivery Unit.

In a statement, Pritchard said the decision came after months of discussions with the secretary of state for health and social care.

“While it has been a hugely difficult decision for me to stand down, I believe now is the right time – with the NHS making continued progress in our recovery, and with the foundations firmly in place to deliver the 10 Year Health Plan,” she said.

Her departure follows scrutiny from two influential House of Commons committees less than a month ago, which discussed her suitability to lead the NHS through what prime minister Keir Starmer has described as the most significant overhaul of the health service.

Sir James Mackey will take over as Transition CEO, working closely with Pritchard over the next month before officially assuming the role on 1 April.

Currently, he serves as chief executive of Newcastle Hospitals NHS Foundation Trust and national director of Elective Recovery. Mackey previously served as chief executive of NHS Improvement.

Mackey acknowledged Pritchard’s significant contributions, stating, “Amanda has done an extraordinary job of leading the NHS through this difficult period.”

He added: I have always been very proud to work for the NHS and it will be an honour to lead the service through the next phase as we radically reshape the role of NHS England and work with the Government to build an NHS that is fit for the future through the 10 Year Health Plan.

Mackey also expressed gratitude to Newcastle Hospitals, where he has been chief executive for the past 14 months.

He said: “I am sad to be stepping away from Newcastle Hospitals, and it has been a privilege to be part of the dedicated and talented team there over the last 14 months. I have learned a great deal from colleagues there as we have successfully tackled some difficult issues and made significant improvements. I look forward to rejoining them in due course.”

Health secretary Wes Streeting praised Amanda’s leadership during the biggest health emergency in modern history.

He also applauded her for steering NHS England during “turbulent political waters and six secretaries of state” in her time as chief executive.

“She has led with integrity and unwavering commitment,” he said.

Streeting also expressed confidence in Mackey’s leadership, stating: “He knows the NHS inside out, can see how it needs to change, and will work with the speed and urgency we need.”

More For You

Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less
Three pharmacists named in NIHR’s latest cohort of senior investigators

L-R: Professor David Alldred; Professor Rachel Elliott and Professor Ian Maidment.

Three pharmacists appointed as NIHR senior investigators

The National Institute for Health and Care Research (NIHR) has announced its latest cohort of senior investigators, including three distinguished pharmacists.

David Alldred, professor of medicines use and safety at the University of Leeds; Rachel Elliott, professor of health economics at the University of Manchester; and Ian Maidment, professor in clinical pharmacy at Aston University, have been named in the list of 39 new appointments, alongside 19 reappointed senior investigators.

Keep ReadingShow less
Vaccine-preventable infections costing UK billions

Effective interventions are needed to prevent hospitalisations

Vaccine-preventable infections costing UK billions

Effective interventions are having a positive impact but more needs to be done to combat vaccine-preventable infections after data revealed today showed that it accounted for 20 per cent of hospital bed usage in the UK between 2023 to 2024 at a cost of almost £6 billion.

The return of social mixing, international travel and migration following the COVID-19 pandemic have contributed to the rise in both endemic disease and vaccine-preventable infections, according to the UK Health Security Agency's (UKHSA).

Keep ReadingShow less
Economic analysis of pharmacy finances will be published ‘imminently’ - Stephen Kinnock

Stephen Kinnock also confirms that the outcome of the negotiations with CPE will be announced "very soon."

parliamentlive.tv

NPA collective action “premature, unnecessary and detrimental to patients” - Stephen Kinnock

Health Minister Stephen Kinnock has announced that the government will be releasing the independent economic analysis of pharmacy finances “imminently.”

Responding to a question from shadow health minister Dr. Luke Evans in Parliament today (25), Kinnock criticised the National Pharmacy Association’s (NPA) collective action as “premature, unnecessary, and detrimental to community pharmacy patients.”

Keep ReadingShow less